5, 2026, the newly approved GLP-1 pills for weight loss had been prescribed to about 170,000 people, outpacing the rate of adoption of other GLP-1 medications
It is FDA-approved to treat both type 2 diabetes and, more recently, obesity
Sango K, Takaku S, Tsukamoto M, Niimi N, Yako H
In some cases, a medical provider may recommend a dose adjustment or a shift in strategy rather than stopping the medication altogether
Which clinical signals does the post say a provider watches when adjusting tirzepatide
Err on the side of caution and discontinue use when planning pregnancy or while nursing